RARE Stock Forecast & Price Target
RARE Stock
Price Forecast
The average stock forecast for
Ultragenyx Pharmaceutical Inc (RARE) in the next 12 months is 51.96 USD. This price target corresponds to an upside
of
104.74%. The range of stock forecasts for RARE is 25.25 - 100.80 USD.
Based on the ratings of 25 analysts, the consensus recommendation for RARE is
BUY.
| Target |
Low |
Average |
Median |
High |
| Price (USD) |
25.25 |
51.96 |
48.45 |
100.80 |
| Upside |
-0.51% |
104.74% |
90.90% |
297.16% |
Recommendation Trends
The latest consensus rating for RARE is "BUY". This is the average
recommendation of 25 analysts: 0 strong sell,
0 sell, 3 hold, 14 buy, 8 strong buy. In the previous period, 26 analysts also majorly recommmended
"BUY" for RARE.
RARE Financial Stock
Forecast
Revenue This Year
from 673.00M
Revenue Next Year
from 756.82M